Endoclot Plus Co., Ltd.
Privately founded medical device company based in Santa Clara, California, focused on biomaterial-based therapies and delivery systems for gastrointestinal endoscopy. The company develops plant-starch–derived absorbable hemostatic particles and adhesive polymers and designs endoscopic powder and gel delivery systems. Manufacturing of product lines is performed at a facility in Suzhou, China. The company supports clinical and preclinical evaluation of its technologies and has obtained regulatory clearances and CE marking for multiple products.
Industries
Nr. of Employees
small (1-50)
Endoclot Plus Co., Ltd.
5201 Great America Parkway, Suite 526, Santa Clara, CA 95054, USA
Patents
Products
Endoscopic absorbable polysaccharide hemostatic powder system (single-use)
Single-use system combining absorbable polysaccharide particles and a powder delivery applicator for topical control of bleeding during endoscopy.
Adhesive hemostatic polymer powder (single-use)
Hydrophilic adhesive polymer powder designed to form a gel barrier on contact with blood or GI fluids and provide prolonged adhesion to mucosal wounds.
Submucosal injection system (starch-derived particle solution + spiral plunger syringe)
System for submucosal lift comprising starch-derived absorbable particles mixed with saline and delivered using a spiral-plunger syringe compatible with standard endoscopic injection needles.
Endoscopic absorbable polysaccharide hemostatic powder system (single-use)
Single-use system combining absorbable polysaccharide particles and a powder delivery applicator for topical control of bleeding during endoscopy.
Adhesive hemostatic polymer powder (single-use)
Hydrophilic adhesive polymer powder designed to form a gel barrier on contact with blood or GI fluids and provide prolonged adhesion to mucosal wounds.
Submucosal injection system (starch-derived particle solution + spiral plunger syringe)
System for submucosal lift comprising starch-derived absorbable particles mixed with saline and delivered using a spiral-plunger syringe compatible with standard endoscopic injection needles.
Services
Provision of IFUs, quickstart guides, brochures and procedural videos to support clinicians in device setup and use during endoscopic procedures.
Commercial distribution and regional partnership management to supply products through authorized distributors and exclusive distribution agreements.
Provision of IFUs, quickstart guides, brochures and procedural videos to support clinicians in device setup and use during endoscopic procedures.
Commercial distribution and regional partnership management to supply products through authorized distributors and exclusive distribution agreements.
Expertise Areas
- Biomaterials for gastrointestinal hemostasis
- Endoscopic device engineering and delivery systems
- Preclinical and clinical study support in GI endoscopy
- Medical device regulatory submissions and CE/FDA processes
Key Technologies
- Absorbable polysaccharide hemostats
- Adhesive hemostatic polymers resistant to GI conditions
- Endoscopic powder applicator with powder/air mixing chamber
- Spiral-plunger syringe for high-viscosity endoscopic injection
News & Updates
Announcement of FDA clearance for the polysaccharide hemostatic system in February 2021.
Announcement of FDA clearance for the submucosal lifting product in January 2020.
Applicator received 510(k) clearance in January 2017.
CE Mark approvals for multiple products: hemostatic powder (September 2011), adhesive (May 2018), and submucosal injection system (June 2020).
Announcements of exclusive regional distribution agreements and partnership expansions documented on the company news page.
Announcement of FDA clearance for the polysaccharide hemostatic system in February 2021.
Announcement of FDA clearance for the submucosal lifting product in January 2020.
Applicator received 510(k) clearance in January 2017.
CE Mark approvals for multiple products: hemostatic powder (September 2011), adhesive (May 2018), and submucosal injection system (June 2020).
Announcements of exclusive regional distribution agreements and partnership expansions documented on the company news page.